Electropharmacologic characteristics of ventricular proarrhythmia induced by ibutilide

Yi Jen Chen, Ming Hsiung Hsieh, Chuen Wang Chiou, Shih Ann Chen

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

The purpose of this study was to evaluate in vivo the proarrhythmic effects of ibutilide in dogs with or without ventricular hypertrophy. Fourteen dogs received repeated experiments both during the acute and chronic phases (8 weeks, with ventricular hypertrophy) of complete atrioventricular (AV) block. Twelve-lead ECG, monophasic action potentials in the left and right ventricle were recorded before and after each dose of ibutilide (0.01- 0.08 mg/kg) during different ventricular rates. In these dogs, ibutilide increased QT interval, biventricular APD90, interventricular ΔAPD90 (difference between the left and right ventricular APD90), and QT dispersion, and induced early after depolarizations in a dose-dependent manner. The interventricular AAPD90, QT dispersion, and increases of QT interval were more pronounced during slower ventricular rates. There were greater QT interval, biventricular APD90, interventricular ΔAPD90, and QT dispersion values during chronic AV block than during acute AV block. Moreover, ibutilide can induce higher incidences of early afterdepolarizations and torsades de pointes [six (43%) of 14 versus 0 of 14; p <0.05] during chronic AV block than during acute AV block. In conclusion, ibutilide can prolong ventricular repolarization and increase dispersion of ventricular repolarization in a dose-dependent and reverse rate-dependent manner. The high incidence of torsades de pointes in the dogs during chronic AV block suggests the importance of ventricular hypertrophy in the occurrence of ibutilide-induced proarrhythmia.

Original languageEnglish
Pages (from-to)237-247
Number of pages11
JournalJournal of Cardiovascular Pharmacology
Volume34
Issue number2
DOIs
Publication statusPublished - Aug 1999

Fingerprint

Atrioventricular Block
Dogs
Hypertrophy
Torsades de Pointes
Heart Ventricles
Incidence
Action Potentials
ibutilide
Electrocardiography

Keywords

  • Ibutilide
  • Long-QT syndrome
  • Reverse rate dependent

ASJC Scopus subject areas

  • Pharmacology
  • Cardiology and Cardiovascular Medicine

Cite this

Electropharmacologic characteristics of ventricular proarrhythmia induced by ibutilide. / Chen, Yi Jen; Hsieh, Ming Hsiung; Chiou, Chuen Wang; Chen, Shih Ann.

In: Journal of Cardiovascular Pharmacology, Vol. 34, No. 2, 08.1999, p. 237-247.

Research output: Contribution to journalArticle

@article{6bfa89a12e2f4daaba375ecac3b5f325,
title = "Electropharmacologic characteristics of ventricular proarrhythmia induced by ibutilide",
abstract = "The purpose of this study was to evaluate in vivo the proarrhythmic effects of ibutilide in dogs with or without ventricular hypertrophy. Fourteen dogs received repeated experiments both during the acute and chronic phases (8 weeks, with ventricular hypertrophy) of complete atrioventricular (AV) block. Twelve-lead ECG, monophasic action potentials in the left and right ventricle were recorded before and after each dose of ibutilide (0.01- 0.08 mg/kg) during different ventricular rates. In these dogs, ibutilide increased QT interval, biventricular APD90, interventricular ΔAPD90 (difference between the left and right ventricular APD90), and QT dispersion, and induced early after depolarizations in a dose-dependent manner. The interventricular AAPD90, QT dispersion, and increases of QT interval were more pronounced during slower ventricular rates. There were greater QT interval, biventricular APD90, interventricular ΔAPD90, and QT dispersion values during chronic AV block than during acute AV block. Moreover, ibutilide can induce higher incidences of early afterdepolarizations and torsades de pointes [six (43{\%}) of 14 versus 0 of 14; p <0.05] during chronic AV block than during acute AV block. In conclusion, ibutilide can prolong ventricular repolarization and increase dispersion of ventricular repolarization in a dose-dependent and reverse rate-dependent manner. The high incidence of torsades de pointes in the dogs during chronic AV block suggests the importance of ventricular hypertrophy in the occurrence of ibutilide-induced proarrhythmia.",
keywords = "Ibutilide, Long-QT syndrome, Reverse rate dependent",
author = "Chen, {Yi Jen} and Hsieh, {Ming Hsiung} and Chiou, {Chuen Wang} and Chen, {Shih Ann}",
year = "1999",
month = "8",
doi = "10.1097/00005344-199908000-00009",
language = "English",
volume = "34",
pages = "237--247",
journal = "Journal of Cardiovascular Pharmacology",
issn = "0160-2446",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Electropharmacologic characteristics of ventricular proarrhythmia induced by ibutilide

AU - Chen, Yi Jen

AU - Hsieh, Ming Hsiung

AU - Chiou, Chuen Wang

AU - Chen, Shih Ann

PY - 1999/8

Y1 - 1999/8

N2 - The purpose of this study was to evaluate in vivo the proarrhythmic effects of ibutilide in dogs with or without ventricular hypertrophy. Fourteen dogs received repeated experiments both during the acute and chronic phases (8 weeks, with ventricular hypertrophy) of complete atrioventricular (AV) block. Twelve-lead ECG, monophasic action potentials in the left and right ventricle were recorded before and after each dose of ibutilide (0.01- 0.08 mg/kg) during different ventricular rates. In these dogs, ibutilide increased QT interval, biventricular APD90, interventricular ΔAPD90 (difference between the left and right ventricular APD90), and QT dispersion, and induced early after depolarizations in a dose-dependent manner. The interventricular AAPD90, QT dispersion, and increases of QT interval were more pronounced during slower ventricular rates. There were greater QT interval, biventricular APD90, interventricular ΔAPD90, and QT dispersion values during chronic AV block than during acute AV block. Moreover, ibutilide can induce higher incidences of early afterdepolarizations and torsades de pointes [six (43%) of 14 versus 0 of 14; p <0.05] during chronic AV block than during acute AV block. In conclusion, ibutilide can prolong ventricular repolarization and increase dispersion of ventricular repolarization in a dose-dependent and reverse rate-dependent manner. The high incidence of torsades de pointes in the dogs during chronic AV block suggests the importance of ventricular hypertrophy in the occurrence of ibutilide-induced proarrhythmia.

AB - The purpose of this study was to evaluate in vivo the proarrhythmic effects of ibutilide in dogs with or without ventricular hypertrophy. Fourteen dogs received repeated experiments both during the acute and chronic phases (8 weeks, with ventricular hypertrophy) of complete atrioventricular (AV) block. Twelve-lead ECG, monophasic action potentials in the left and right ventricle were recorded before and after each dose of ibutilide (0.01- 0.08 mg/kg) during different ventricular rates. In these dogs, ibutilide increased QT interval, biventricular APD90, interventricular ΔAPD90 (difference between the left and right ventricular APD90), and QT dispersion, and induced early after depolarizations in a dose-dependent manner. The interventricular AAPD90, QT dispersion, and increases of QT interval were more pronounced during slower ventricular rates. There were greater QT interval, biventricular APD90, interventricular ΔAPD90, and QT dispersion values during chronic AV block than during acute AV block. Moreover, ibutilide can induce higher incidences of early afterdepolarizations and torsades de pointes [six (43%) of 14 versus 0 of 14; p <0.05] during chronic AV block than during acute AV block. In conclusion, ibutilide can prolong ventricular repolarization and increase dispersion of ventricular repolarization in a dose-dependent and reverse rate-dependent manner. The high incidence of torsades de pointes in the dogs during chronic AV block suggests the importance of ventricular hypertrophy in the occurrence of ibutilide-induced proarrhythmia.

KW - Ibutilide

KW - Long-QT syndrome

KW - Reverse rate dependent

UR - http://www.scopus.com/inward/record.url?scp=0032807829&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032807829&partnerID=8YFLogxK

U2 - 10.1097/00005344-199908000-00009

DO - 10.1097/00005344-199908000-00009

M3 - Article

C2 - 10445675

AN - SCOPUS:0032807829

VL - 34

SP - 237

EP - 247

JO - Journal of Cardiovascular Pharmacology

JF - Journal of Cardiovascular Pharmacology

SN - 0160-2446

IS - 2

ER -